Cargando…
Correction to: Elagolix: First Global Approval
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302981/ https://www.ncbi.nlm.nih.gov/pubmed/30430369 http://dx.doi.org/10.1007/s40265-018-1014-3 |
| _version_ | 1783382089680289792 |
|---|---|
| author | Lamb, Yvette N. |
| author_facet | Lamb, Yvette N. |
| author_sort | Lamb, Yvette N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6302981 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63029812019-01-04 Correction to: Elagolix: First Global Approval Lamb, Yvette N. Drugs Correction Springer International Publishing 2018-11-15 2018 /pmc/articles/PMC6302981/ /pubmed/30430369 http://dx.doi.org/10.1007/s40265-018-1014-3 Text en © Springer Nature 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. |
| spellingShingle | Correction Lamb, Yvette N. Correction to: Elagolix: First Global Approval |
| title | Correction to: Elagolix: First Global Approval |
| title_full | Correction to: Elagolix: First Global Approval |
| title_fullStr | Correction to: Elagolix: First Global Approval |
| title_full_unstemmed | Correction to: Elagolix: First Global Approval |
| title_short | Correction to: Elagolix: First Global Approval |
| title_sort | correction to: elagolix: first global approval |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302981/ https://www.ncbi.nlm.nih.gov/pubmed/30430369 http://dx.doi.org/10.1007/s40265-018-1014-3 |
| work_keys_str_mv | AT lambyvetten correctiontoelagolixfirstglobalapproval |